Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study

Coronavirus disease 2019 (COVID-19) has rapidly expanded worldwide. Currently, there are no biomarkers to predict respiratory worsening in patients with mild to moderate COVID-19 pneumonia. Small studies explored the use of Krebs von de Lungen-6 circulating serum levels (sKL-6) as a prognostic bioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellví, Ivan, Castillo, Diego, Corominas, Hèctor, Mariscal, Anaís, Orozco, Sandra, Benito, Natividad, Pomar, Virginia, Baucells, Andrés, Mur, Isabel, de la Rosa-Carrillo, David, Lobo, David, Millan, Ana Milena, Hernández de Sosa, Nerea, Filella, David, Matas, Laia, Martínez-Martínez, Laura, Juarez, Cándido, Casademont, Jordi, Domingo, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393380/
https://www.ncbi.nlm.nih.gov/pubmed/36004366
http://dx.doi.org/10.3389/fmed.2022.973918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393380/
https://www.ncbi.nlm.nih.gov/pubmed/36004366
http://dx.doi.org/10.3389/fmed.2022.973918

Ejemplares similares